Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference | Johnson & Johnson Skip to content

Our Company

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

New Brunswick, NJ (May 7, 2021) — Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference on Tuesday, June 8th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.

###

  • Press Contacts:
    Christina Chan
    (732) 524-6297

    Investor Contacts:
    Christopher DelOrefice
    (732) 524-2955

    Jennifer McIntyre
    (732) 524-3922

This site uses cookies as described in our Cookie Policy. Please click the “Accept” button or continue to use our site if you agree to our use of cookies.

Close cookie banner icon




You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.

More:  Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) ReviewEMA Confirms Overall Benefit-Risk Profile Remains Positive


More from: | Category: Pharmaceutical Company News